openPR Logo
Press release

SCHOLAS and MACOMA have joined forces to slow down Global Warming Quickly and Economically

08-12-2024 09:58 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

SCHOLAS and MACOMA have joined forces to slow down Global Warming

As per the latest global weather reports, 2023 was the hottest year on record, with the planet's average temperature increasing by 1.18 degrees Celsius.

This alarming trend is expected to continue, with this year projected to be even hotter.

Efforts to reverse our planet's warming trends are not just insufficient; they are dangerously slow to counteract the inevitable CO2 emissions.

Image: https://www.abnewswire.com/uploads/9356f424edff1ba9517ea23c5ef74d90.jpeg

However, raising the albedo of urban areas located between 35 degrees below and above the Earth's Equator could rapidly and economically slow global warming. The Pontifical organization Scholas, founded by Pope Francis, has formed a strategic alliance with MACOMA to achieve this ambitious goal.

Installing high solar-reflective coating (Cool Roof) on at least 80% of roofs in the urban areas located in the target zone will have a positive and measurable effect on global climate.

Image: https://www.abnewswire.com/uploads/4513b29a5505e3b52c0b1606d9c30f21.jpeg

Low-income communities lack the financial capacity to install cool roofs on their homes, so Scholas and MACOMA request your cooperation by purchasing the Voluntary Carbon Credits generated by the Scholas and MACOMA Cool Roof Projects.

Pope Francis invites companies, philanthropists, and governments to join "Communis Domus," Scholas's first program with MACOMA to combat global warming.

Please Visit: https://scholasoccurrentes.org/en/scholas-occurrentes-y-macoma-unidos-por-el-medio-ambiente/ and http://www.MACOMA.us

Media Contact
Company Name: MACOMA Environmental Technologies
Contact Person: Cathy Makunga
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=scholas-and-macoma-have-joined-forces-to-slow-down-global-warming-quickly-and-economically]
Phone: 702-951-1401
Address:1664 N Virginia St - Room 112 University
City: Reno
State: Nevada
Country: United States
Website: http://www.MACOMA.us



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SCHOLAS and MACOMA have joined forces to slow down Global Warming Quickly and Economically here

News-ID: 3620502 • Views:

More Releases from ABNewswire

Atopic Dermatitis Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Vanda Pharmaceuticals, TechnoDerma Medicines, Asana BioSciences, Artax Biopharma, Cor
Atopic Dermatitis Clinical, Companies, Therapeutic Assessment, Therapies, Treatm …
DelveInsight's, "Atopic Dermatitis - Pipeline Insight, 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight's analysis indicates that the Atopic Dermatitis (AD) pipeline includes
Hypertriglyceridemia: Clinical Landscape, Companies, Therapeutic Assessment, Treatment Algorithm, and Pipeline Insights | Key Players: NorthSea Therapeutics, Arrowhead Pharmaceuticals, Zhejiang Doer B
Hypertriglyceridemia: Clinical Landscape, Companies, Therapeutic Assessment, Tre …
DelveInsight's, "Hypertriglyceridemia - Pipeline Insight, 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Hypertriglyceridemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. According to DelveInsight, the Hypertriglyceridemia pipeline features 18+ key pharmaceutical companies actively
Electrical Stimulation Devices Market Set for Consistent Expansion Driven by Technological Advancements and Rising Surgical Demand | DelveInsight
Electrical Stimulation Devices Market Set for Consistent Expansion Driven by Tec …
Electrical Stimulation Devices Market By Product Type (Wired Devices And Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2030 owing to the rising prevalence of musculoskeletal disorders and technological innovation in product development The global functional electrical stimulation (FES) devices market is expected to expand
Brain Monitoring Devices Market Set for Consistent Expansion Driven by Technological Advancements and Increasing Surgical Procedures | DelveInsight
Brain Monitoring Devices Market Set for Consistent Expansion Driven by Technolog …
Brain Monitoring Devices market is expected to rise in the upcoming years owing to various factors during the study period, estimates DelveInsight. The global brain monitoring devices market, estimated at USD 5.89 billion in 2023, is expected to grow at a CAGR of 7.27% from 2024 to 2030, reaching approximately USD 9.13 billion by 2030. This growth is primarily attributed to the rising incidence of neurological conditions such as multiple sclerosis,

All 5 Releases